Experienced in Radiation Induced Meningioma

Dr. Tulika Ranjan

Neurology | Oncology
Mary Hitchcock Memorial Hospital
1 Medical Ctr Dr, 
Lebanon, NH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Radiation Induced Meningioma
Mary Hitchcock Memorial Hospital
1 Medical Ctr Dr, 
Lebanon, NH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Tulika Ranjan is a Neurologist and an Oncologist in Lebanon, New Hampshire. Dr. Ranjan is rated as an Experienced provider by MediFind in the treatment of Radiation Induced Meningioma. Her top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Ranjan is currently accepting new patients.

Her clinical research consists of co-authoring 15 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Oncology
Licenses
Internal Medicine in FL
Hospital Affiliations
Mary Hitchcock Memorial Hospital
Catholic Medical Center
Languages Spoken
English
Hindi
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

MARY HITCHCOCK MEMORIAL HOSPITAL
1 Medical Ctr Dr, Lebanon, NH 03756

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: September 09, 2025
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)
A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Drug, Radiation
Study Drugs: Temozolomide, Depatuxizumab
Study Phase: Phase 3
View 3 Less Clinical Trials

14 Total Publications

Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis.
Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis.
Journal: Cancers
Published: October 20, 2025
Similar Doctors
Advanced in Radiation Induced Meningioma
Dr. Amandeep Kalra
Neurology | Oncology | Hematology Oncology
Advanced in Radiation Induced Meningioma
Dr. Amandeep Kalra
Neurology | Oncology | Hematology Oncology
1 Medical Center Dr, 
Lebanon, NH 
 (0.2 miles away)
603-650-5000
Languages Spoken:
English
See accepted insurances

Amandeep Kalra is a Neurologist and an Oncologist in Lebanon, New Hampshire. Dr. Kalra is rated as a Distinguished provider by MediFind in the treatment of Radiation Induced Meningioma. His top areas of expertise are Oligodendroglioma, Astrocytoma, Glioblastoma, and Gliosarcoma.

Experienced in Radiation Induced Meningioma
Dr. Philip M. Skidd
Neurology | Ophthalmology
Experienced in Radiation Induced Meningioma
Dr. Philip M. Skidd
Neurology | Ophthalmology

Mary Hitchcock Memorial Hospital

87 Mcgregor St, 
Manchester, NH 
 (62.0 miles away)
603-695-2500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Philip Skidd is a Neurologist and an Ophthalmologist in Manchester, New Hampshire. Dr. Skidd is rated as an Advanced provider by MediFind in the treatment of Radiation Induced Meningioma. His top areas of expertise are Eyelid Drooping, Ptosis, Optic Nerve Atrophy, Stent Placement, and Transmyocardial Revascularization. Dr. Skidd is currently accepting new patients.

Experienced in Radiation Induced Meningioma
Dr. Alexander Kloman
Neurology
Experienced in Radiation Induced Meningioma
Dr. Alexander Kloman
Neurology

Dartmouth Hitchcock Medical Center

1 Medical Center Dr # 3C, 
Lebanon, NH 
 (2.5 miles away)
603-650-5104
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alexander Kloman is a Neurologist in Lebanon, New Hampshire. Dr. Kloman is rated as an Advanced provider by MediFind in the treatment of Radiation Induced Meningioma. His top areas of expertise are Lewy Body Dementia (LBD), Memory Loss, Neuronal Intranuclear Inclusion Disease (NIID), and Myasthenia Gravis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ranjan's expertise for a condition
ConditionClose
View All 12 Distinguished Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile